In detail, GFAP was assessed in retinal detachment, proliferative vitreoretinopathy, branch retinal venous occlusion, and even malignant melanoma, which illustrated a compromise of the blood–retinal barrier (BRB) [39–42]. This evidence concerns the gene GFAP and proliferative vitreoretinopathy.